Cons pose as bank officials, IGL staff to cheat 3 of Rs 24L

Dr Lal PathLabs shares surged after a strong Q1FY27 earnings beat, driven by higher realisations and price hikes. Brokerages including Nomura, Nuvama and JM Financial raised target prices, citing robust growth outlook, network expansion and improving margins, with continued momentum expected from diagnostics demand and strategic investments.

When help starts hurting: How $2.6tn in aid trapped Africa in poverty

There was little for farmers battling a crash in crop prices and incomes, and funds for agri research were slashed amid growing climate risks and a productive crisis.